Target has signed a 15-year lease for a 135,000-square-foot store at the Rego Park Shopping Center in Queens, New York. The new location will join other major retailers like Costco, Burlington, and Best Buy in the 600,000-square-foot open-air center. This expansion marks another significant retail commitment for Target in the New York market.

Viridian Therapeutics has received FDA approval for Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED), marking it as the second FDA-approved treatment for the condition. Lumvoa is an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, indicated for TED regardless of activity or duration, and plans for an immediate U.S. commercial launch are underway. The therapy distinguishes itself by being the first approved product for TED to show a statistically significant effect in both diplopia response and complete resolution of diplopia in active and chronic disease.

A historic Westside property in Kansas City, formerly a rail yard and more recently occupied by a large fintech firm, is now on the market. The property, located in the Kansas City Terminal Railway Company Roundhouse Historic District, became mostly vacant after fintech layoffs in 2025. This more-than-century-old site is rooted in Kansas City's railroad history and is currently seeking new owners and occupants.

Exicure (NASDAQ: XCUR) is restructuring its board, with director Ham Jung Kyu resigning and two new Class III directors, Han Eui Seok and Go Jin Young, joining effective June 30, 2026, increasing the board size from five to six. Concurrently, the company established a new Compensation Committee, chaired by Mr. Han, to oversee executive compensation. This move aims to enhance corporate governance and board oversight, with Mr. Han deemed independent while Mr. Go will serve as a non-independent director.

Hilton Worldwide Holdings Inc. (NYSE: HLT) will release its second quarter 2026 financial results before the stock market opens on Tuesday, July 28, 2026, followed by a conference call at 9 a.m. EDT. The call will feature Christopher J. Nassetta and Kevin Jacobs, who will discuss company performance and host a Q&A session. A live webcast will be available on the Hilton Investor Relations website, with a replay and transcript posted within 24 hours.

ViaSat Inc. (VSAT) stock has surged over 13% due to significant satellite communication contract wins and increased analyst optimism. Oppenheimer initiated coverage with an "Outperform" rating and a $140 price target, recognizing the scarcity and value of VSAT's global satellite spectrum. Deutsche Bank and Needham also raised their price targets significantly, while new U.S. Space Force contracts and commercial partnerships further bolster the company's outlook.

GE HealthCare Technologies Inc. (NASDAQ: GEHC) has declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2026. This dividend is payable on August 14, 2026, to shareholders of record as of July 24, 2026. The announcement was made on June 30, 2026, and also noted by MT Newswires, confirming the quarterly dividend amount.

Texas Instruments (TXN) has been removed from several value and defensive indexes and added to the Russell 1000 Dynamic and Top 50 indexes due to recent benchmark reconstitutions. This shift may alter how institutional and passive funds gain exposure to TXN and how the company is perceived by investors, moving away from a purely value and defensive narrative towards a large core holding. The reclassification is important for understanding potential index-driven capital flows and changes in shareholder composition, despite the company's strong year-to-date performance.

Varonis Systems, Inc. announced its Data Security Platform has attained GovRAMP Authorization, confirming its compliance with rigorous security standards for state, local, tribal, and educational government agencies. This certification reinforces Varonis's commitment to helping public sector organizations secure critical data and AI, building on its existing portfolio of U.S. and international certifications. The company aims to provide solutions that protect data at scale as agencies accelerate cloud adoption and AI deployment.

Jefferies has reiterated its Buy rating on Copart (CPRT.US) and maintained its price target of $45. This indicates a continued positive outlook from the financial firm regarding the company's stock performance.